ArticleVaccine2022

A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan.

Yoshinori Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.